H Eggers1, M A Kuczyk, A J Schrader, S Steffens. 1. Klinik für Urologie und urologische Onkologie, Medizinische Hochschule Hannover, Carl-Neubergstraße 1, 30625, Hannover, Deutschland.
Abstract
BACKGROUND: Overweight presents a growing problem in our society; therefore, there is an increasing interest to understand the influence of obesity on urological forms of cancer. AIM: In prostate cancer the development of a more aggressive phenotype seems to correlate with obesity. In renal cell cancer (RCC) obesity is both, a risk factor for occurrence -and is also associated with an improved tumour-specific survival in patients with organ-confined disease following kidney surgery as well as overall survival of patients with advanced disease receiving VEGF(R)-targeted treatment. In contrast, even though an association between body mass index (BMI) and bladder cancer has been described the role of obesity in bladder cancer remains largely unclear as published data are contradictory. RESULTS: An update on currently available data focusing on the relationship between obesity and genitourinary malignancies is given in this review; however, basic research which is necessary to define the biological and metabolic effects associated with obesity and which might affect the development and progression of urological cancers, is indicated.
BACKGROUND: Overweight presents a growing problem in our society; therefore, there is an increasing interest to understand the influence of obesity on urological forms of cancer. AIM: In prostate cancer the development of a more aggressive phenotype seems to correlate with obesity. In renal cell cancer (RCC) obesity is both, a risk factor for occurrence -and is also associated with an improved tumour-specific survival in patients with organ-confined disease following kidney surgery as well as overall survival of patients with advanced disease receiving VEGF(R)-targeted treatment. In contrast, even though an association between body mass index (BMI) and bladder cancer has been described the role of obesity in bladder cancer remains largely unclear as published data are contradictory. RESULTS: An update on currently available data focusing on the relationship between obesity and genitourinary malignancies is given in this review; however, basic research which is necessary to define the biological and metabolic effects associated with obesity and which might affect the development and progression of urological cancers, is indicated.
Authors: Jay H Fowke; Saundra S Motley; Marcia Wills; Michael S Cookson; Raoul S Concepcion; Charles W Eckstein; Sam S Chang; Joseph A Smith Journal: Cancer Causes Control Date: 2007-03-01 Impact factor: 2.506
Authors: K Golka; T Seidel; H Dietrich; G Roth; C Rötzel; R Thier; F Geller; T Reckwitz; H Schulze Journal: Aktuelle Urol Date: 2005-09 Impact factor: 0.658
Authors: Stephen J Freedland; Elizabeth A Platz; Joseph C Presti; William J Aronson; Christopher L Amling; Christopher J Kane; Martha K Terris Journal: J Urol Date: 2006-02 Impact factor: 7.450
Authors: J Ferlay; E Steliarova-Foucher; J Lortet-Tieulent; S Rosso; J W W Coebergh; H Comber; D Forman; F Bray Journal: Eur J Cancer Date: 2013-02-26 Impact factor: 9.162
Authors: Cheryl T Lee; Rodney L Dunn; Bert T Chen; Daya P Joshi; Jaqueline Sheffield; James E Montie Journal: J Urol Date: 2004-10 Impact factor: 7.450